GGrantIndex
Sort

40,608 grants matching prostate cancer

A novel T-cell subset able to kill relapsed cancers

$369,431
Qing Yi · Methodist Hospital Research Institute · R01 · FY2020 · CA

Effects of Radiation on Brain Microvasculature and Cognition

$369,395
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2010 · NS

Heparan Sulfate Proteoglycans in Bone Stromal Metastasis

$369,377
Mary C Farach-Carson · Cedars-Sinai Medical Center · P01 · FY2011 · CA

Inferring Kinase Activity from Tumor Phosphoproteomic Data

$369,343
Kristen M Naegle · University Of Virginia · U01 · FY2024 · CA

Men of African Ancestry are primed for aggressive prostate cancer by high prostate androgens driven by vitamin D deficiency and megalin

$369,337
Larisa Nonn · University Of Illinois At Chicago · R01 · FY2025 · CA

Novel deregulated genes in the etiology and progression of human prostate cancer

$369,322
Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2010 · CA

Protein Biosensor Arrays Based on Nanomaterials

$369,296
James F. Rusling · University Of Connecticut Storrs · R01 · FY2011 · EB

Program for the Elimination of Cancer Disparities (PECAD)

$369,288
Graham A Colditz · Washington University · U54 · FY2015 · CA

CYTOGENETICS AND BIOCHEMISTRY OF PROSTATE CANCER

$369,259
Case Western Reserve University · R01 · FY2001 · CA

Leadership and Administration

$369,253
Peter S Nelson · Fred Hutchinson Cancer Research Center · P50 · FY2016 · CA

Stress-activated signaling in prostate cancer

$369,214
George A Kulik · Wake Forest University Health Sciences · R01 · FY2011 · CA

Use and Outcomes of Radiation Therapy for Medicare Patients with Common Cancers

$369,181
Cary P Gross · Yale University · R01 · FY2012 · CA

Prostate Cancer Screening: Fostering Informed Decisions

$369,141
Georgetown University · R01 · FY2004 · CA

Diagnostic Therapeutic Targets in Prostate Cancer

$369,102
Andrei V Gudkov · Roswell Park Cancer Institute Corp · R01 · FY2007 · CA

ANDROGEN RECEPTOR AND PROSTATE CANCER RISK IN CHINESE

$369,015
University Of Southern California · R01 · FY2003 · CA

STIMULTANEOUS GENOME-WIDE CHARACTERIZATION OF SOMATIC ALTERATIONS IN IMPRINTING, DNA METHYLATION, AND GENOMIC COPY NUMBER IN PROSTATE CANCER

$369,000
The Johns Hopkins University · · FY2008 · Department of the Army

ANDROGEN REGULATION OF MICRORNA IN PROSTATE CANCER

$368,998
The Johns Hopkins University · · FY2008 · Department of the Army

A New Mechanism for Castration Resistant Prostate Cancer

$368,984
Zijie Sun · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA

A New Mechanism for Castration Resistant Prostate Cancer

$368,984
Zijie Sun · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA

The contributions of sensory nerves to bone metastasis and associated bone pain

$368,981
Yusuke Shiozawa · Wake Forest University Health Sciences · R01 · FY2023 · CA

The contributions of sensory nerves to bone metastasis and associated bone pain

$368,964
Yusuke Shiozawa · Wake Forest University Health Sciences · R01 · FY2022 · CA

Electromobility Focusing for Separation of Proteins

$368,939
Brigham Young University · R01 · FY2004 · GM

The Par-4/PKCz complex in prostate cancer

$368,938
Maria Teresa Diaz Meco Conde · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA

Androgen Signaling in Neoplastic Prostate Growth

$368,920
Fred Hutchinson Cancer Research Center · R01 · FY2003 · DK

US Prostate Cancer Detection with Dutasteride Pretreatment

$368,892
Ethan J Halpern · Thomas Jefferson University · R01 · FY2008 · CA